Oxular Limited
Oxford, GB· latest recorded location
Oxular Limited is named on 5 US grants and 11 published applications in this corpus. Its most frequent classification is A61F (Filters implantable into blood vessels).
- Granted patents
- 5
- Published applications
- 11
- Inventors
- 12
- Granted in 2026 so far
- 0
- Most recent grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 0 | 3 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 16 documents
Recent patents
- Ophthalmic drug compositions19 Aug 2025US 12,390,363 B2
- Ophthalmic delivery device and ophthalmic drug compositions11 Apr 2023US 11,622,884 B2
- Sterile lyophilized drug compositions and methods for treating ocular diseases or conditions31 Jan 2023US 11,564,834 B2
- Ophthalmic injection device26 Oct 2021US 11,154,420 B2
- Ophthalmic delivery device24 Aug 2021US 11,096,822 B2
- Ophthalmic drug compositions8 Jan 2026US 2026/0007543 A1
- Ophthalmic Drug Compositions9 Nov 2023US 2023/0355431 A1
- Pharmaceutical Compositions, Formulations And Methods For The Treatment Of Retinoblastoma29 Dec 2022US 2022/0409560 A1
- Ophthalmic Drug Compositions17 Mar 2022US 2022/0079878 A1
- Ophthalmic Delivery Device And Ophthalmic Active Agent Containing Compositions10 Jun 2021US 2021/0169689 A1
Most cited
By later US patents